The comprehension of the pathogenesis of epilepsy finds a new impulse in studies on non-linear dynamics of EEG signals and in the growing genetic molecular evidence of the mitochondrial origin of this disease. These data are consistent with the information known by Quantum Biophysical Semeiotics that clinically investigates microcirculation both on a functional (i.e. by studying its non-linear dynamics), and on a structural viewpoint. Microcirculatory dysfunctions reflect those of a genetically altered mit-DNA and of a functional mitochondrial cytopathy known as Congenital Acidosic Enzyme-Metabolic Histangiopathy, originating from this mutation and which is particularly intense both in patients with epilepsy and in those with Inherited Real Risk of epilepsy. Preclinical diagnosis of Inherited Real Risk of epilepsy presents the opportunity to examine subjects with a predisposition to this disease since birth in order to perform an efficient pre-primary and primary prevention. In our case report, an integrated quantum therapy applied to a child with Inherited Real Risk of epilepsy in strong evolution provides encouraging satisfactory results.
Introduction 1

The Pathogenesis of Epilepsy: An Overview
The complex pathogenesis of epilepsy has not yet been fully explained in a unique, consistent, and harmonic form according to shared scientific opinion (Yu and Pearl, 2013; Papetti et al., 2013; Frye, 2015) . During the past few decades, scientists have tried to explain epilepsy as a primary metabolic disorder. According to the actual scientific knowledge, the latest ring of each metabolic or biochemical influence able to modify predisposition to epilepsy is the polarization level of the neuronal membrane, i.e. the difference in potential between the inside and the outside of a cell. Currently, this highlights the important role of the mitochondrion in the etiopathogenesis of epilepsy. In particular, a key role is played by the sodium-potassium pump, also called ATPdependant Na+/K+ (Na+/K+ ATPase) pump: this is an enzyme located in cellular membranes which is strictly related to mitochondrial activity. For this reason, epilepsy is supposed to be a mitochondrial disease in some studies (Zsurka and Kunz, 2010; Folbergrová and Kunz, 2012; Lee, 2012; Zsurka and Kunz, 2015) .
Mitochondrial dysfunctions cause cellular dysfunction, also known as mitochondrial cytopathy. Mitochondrial cytopathies (Schmiedel et al., 2003) are the basis of mitochondrial diseases, which are often caused by mutations, acquired or maternally inherited, in the mitochondrial DNA or nuclear genes that code for respiratory chain complexes in mitochondria. There is compelling evidence for the direct involvement of mitochondria in certain neurodegenerative disorders, such as Parkinson's disease (Banerjee et al., 2009; Guerra de Souza, 2016 ). Friedreich's ataxia (FRDA) (Baron et al., 2007) , amyotrophic lateral sclerosis (ALS) (Baron et al., 2007) , Huntington's disease (Graeber and Muller, 1998) , myoclonic epilepsy (Khurana et al., 2013) , and temporal lobe epilepsy (TLE) (Waldbaum and Patel, 2010) . This suggests that the critical factor which determines the survival of neurons in neurodegenerative disorders is the degree of mit-DNA damage and the maintenance of an appropriate mit-DNA copy number (Graeber and Müller, 1998; Baron et al., 2007) . Mitochondrial diseases involve multiple organs and show heterogeneous and unpredictable progression. The most common clinical presentation of mitochondrial diseases is encephalomyopathy, and epileptic seizures can frequently occur as a presenting sign of mitochondrial encephalopathy. Whether mitochondrial dysfunction or epilepsy is the cause or consequence is still debatable. Epileptic phenotypes vary in different mitochondrial diseases (Kang et al., 2013) . Oxidative stress and mitochondrial dysfunction are emerging as key factors that not only result from epileptic seizures, but may also contribute to epileptogenesis as well (Waldbaum and Patel, 2010) . The mitochondrion has an essential role in neuronal excitability and survival. It is a key cellular structure involved in a great number of metabolic functions such as ATP synthesis by oxidative phosphorylation, tricarboxylic acid cycle or fatty acid oxydation, Fe/S Cluster production, and so on. These pathways are fundamental for biological processes such as cell proliferation or death. Some mitochondria dysfunctions of the central nervous system are responsible for several neurological diseases and age-related neurodegenerative disorders, including Alzheimer's and Parkinson's diseases (Gurses et al., 2014) .
The above-cited genetic and biochemical data highlight different mechanisms by which mitochondrial bioenergetics is altered in the hereditary defects of complex I (Papa et al., 2009) . Mitochondrial diseases are frequently caused by a disruption of the respiratory chain. Nevertheless, other mitochondrial functions, including organelles dynamics or metabolite transport, could also be involved in such pathologies (Molinari, 2010) . In addition to being responsible for energy production, mitochondria also play a crucial role in the maintenance of intracellular calcium homeostasis and generation of reactive oxygen species and mechanisms of cell death, but data about the role of mitochondria in epilepsy are relatively scarce. Mitochondrial genome analysis is rarely carried out in the investigation of various diseases, including epilepsy. In mesial temporal lobe epilepsy (MTLE) -hippocampal sclerosis (HS) -cases, mitochondrial genome analysis showed evidence of mitochondrial dysfunctions caused by important mutations associated with epilepsy (Zhao et al., 2008; Zhang et al., 2013) . There are similar evidences in Early Infantile Epileptic Encephalopathy (Palmieri, 2008) .
Another key factor seemingly not related to the pathogenesis of epilepsy originating from mitochondrial mutations is the predictability or non-predictability of epileptic seizures. Throughout the years, many non-linear analyses have been conducted on various epilepsy cases (Ferri et al., 2001; Litt and Echauz, 2002) . Children with electrical status epilepticus during slow-wave sleep (ESES), for example, show a profound alteration of their EEG dynamics with the occurrence, during sleep, of low-dimensional chaotic structure able to modify their brain functioning during sleep (Sabesan et al., 2003; Chaovalitwongse et al., 2005; Yambe et al., 2005; Zhu et al., 2014) . Using different statistical measures, results agree and are consistent with one another: EEG non-linear signals are chaotic under normal physiological conditions, while signals tend to linear regularity in epilepsy cases (Wang et al., 2007; Good et al., 2010) . Epileptic seizures can therefore be predicted through the chaotic analysis of EEG signals (Rosso, 2007; Raiesdana et al., 2008; Gao et al., 2011; Korsakova et al., 2011) .
The mitochondrial nature of epileptic diseases and the loss of non-linear deterministic chaos in epilepsy are two core aspects of the clinical investigation of Quantum Biophysical Semeiotics (QBS) and of its bedside diagnosis, which presents the opportunity to obtain eISSN 1303-5150 www.neuroquantology.com important data for a better comprehension of the pathogenesis of epilepsy, its genetic predisposition, and its Inherited Real Risk (Stagnaro, 2004a ). This will support performing an original pre-primary and primary prevention.
Experimental Section: Method and Material
Inherited Real Risk of Epilepsy: Physiopathology
The background for all mitochondrial diseases studied by QBS is a particular cell suffering -or functional mitochondrial cytopathy (Stagnaro, 1985) , known as Congenital Acidosic EnzymeMetabolic Histangiopathy (CAEMH). If and where the CAEMH is most intensely present, this is a sign of a locally highly altered mit-DNA and, consequently, of tissue suffering and functional impairment, according to mitochondrial heteroplasmy, both endo-and inter-cellular. The result is the formation of one or more QBS constitutions which predispose the organism to some of the most serious degenerative diseases, such as type 2 diabetes, mellitus, cardiovascular diseases, any form of cancer, solid or liquid, and neurodegenerative diseases (Stagnaro and Neri, 2004) .
The QBS constitution (Stagnaro, 2004a) , whose presence can be diagnosed in every individual since birth by means of a stethoscope, is the initial preclinical stage of a disease which can evolve into an Inherited Real Risk (IRR) of a specific pathology (Stagnaro, 2009 Constitutions do not necessarily evolve into disease, as not all individuals with the pathological constitution develop its corresponding disorder in their life. When it does happen, however, the first thing to be examined is the IRR: an indicator of a possible slow and gradual shift to a pathological condition, which is always worsened, but never caused, by its environmental risk factors. IRR diagnosis therefore has a crucial role in QBS, allowing to diagnose the presence of a Real Risk of epilepsy already since birth, and thus confirming the mitochondrial nature of this disease, both if hereditary or acquired, as already pointed out by several authors in the previous section. To understand the pathogenesis of epilepsy, especially at its initial preclinical stage, according to QBS, it is necessary to analyze the data provided by clinical microangiology , a QBS branch which studies microcirculation both on the functional and on the structural viewpoint.
Studying microcirculatory dynamics and structures and analyzing the blood flow in arterioles, venules, nutritional capillaries, as well as examining the Endo-arteriolar Blocking Devices (EBDs), which are blood regulatory devices, provides important qualitative and quantitative information for a fine and detailed diagnosis. EBDs are tiny contractible and physiologically flexible structures which alternately open and close to regulate blood flow in microcirculation, that is the local flow-motion.
What reveals structural mutation, or microcirculatory remodeling, which grows together with functional mutation, is the presence of pathological EBDs. These are anatomically and structurally pathological, stiffer, and more obstructing than the physiological ones. Therefore, the opening and closing system of these 'tiny valves' is not flexible, harmonic, and contractible as in the physiological one, but stiff and obstructing. This has repercussions on the flow-motion, as can be seen in non-linear dynamics of microcirculatory oscillations, which are physiologically of a deterministic chaotic type, but they lose complexity already in the stage preceding the disease, i.e., pre-clinical diagnosis of IRR of pathology, while gradually tending to linearity when the disease has set in (Stagnaro and Neri, 2004; This is confirmed by the progressive reduction in functional and structural complexity which reflects functional and structural mutations in microcirculation. Structural complexity is geometrically represented by the non-linear dynamic system equilibria observed. This equilibrium physiologically consists of a chaotic attractor (phase space reconstructed equilibrium), which can deteriorate into more simple (low-complexity) orders, such as a periodic equilibrium -limited cycle attractor (pathological IRR) -or a fixed equilibrium (disease at a chronic stage) (Stagnaro and Neri, 2004 ).
In the case of an IRR of epilepsy, statistical invariants measuring microcirculatory non-linear dynamics, i.e. fractal Dimension (fD) evaluation (Stagnaro-Neri et al., 1996; Stagnaro-Neri and Stagnaro 1994; 1997) , reveal a loss in complexity eISSN 1303-5150 www.neuroquantology.com which shows biological evidence in microcirculatory activity already since birth. This loss is constant in time and it might slowly reduce in conjunction with a slow progressive degenerative preclinical process (IRR evolution into disease). After crossing a critical threshold, this process could degenerate in an epileptic seizure or an epileptic equivalent. The measure of deterministic chaos is therefore a useful diagnostic tool both in preclinical and clinical stages of epilepsy.
Microvessel oscillations are also crucial to investigate the physiopathology of epilepsy and reveal the key role of mit-DNA mutation and of CAEMH in classifying epilepsy as a mitochondrial disease. This is important to define a pre-primary and primary prevention strictly related to its pathogenesis in view of an improvement in mitochondrial respiration, tissue oxygenation and tissue protection as well as of a retroactive genetic intervention into the altered mitochondrial genome. In other words, microcirculation is where all human tragedies begin and end. The genetically altered mit-DNA causing the CAEMH, which in turn can generate one or more QBS constitutions able to evolve -although not necessarily -into pathological IRRs, has always equivalents in the behavior of biologic systems, and in microcirculation in particular. Besides genetic mutation, QBS diagnosis allows to identify specific corresponding local mutations in microcirculatory activity and in its structures (i.e., EBDs, anastomosis (AVA)).
Like all IRRs, the IRR of epilepsy too can undergo many stages with different preclinical variants: from initial stage Real Risk to Real Risk in strong evolution, which is the stage before the formation of the epileptic focus and the appearance of the disease. This progressive degeneration happens simultaneously with and reflects what happens in microcirculation, the number of pathological EBDs increases with time, vasomotility and vasomotion progressively dissociate from each other, although the organism continuously produces new compensatory processes for microcirculatory remodeling. So, while the situation is getting worse and worse in the micro-world, nothing yet reveals outside in the macro-world, for example in the blood flow along vessels and arteries. This is the main reason why only the QBS bedside diagnosis is able to objectively verify pre-metabolic syndromes, because it is able to quantify microcirculatory dynamics and structures and give them a diagnostic meaning and scope. Pathological EBDs continue to increase in number, and vasomotility and vasomotion become more and more different, microcirculatory remodeling is always greater, more continuous and intense, until the organism finally exhausts its compensatory action. This is the point at which the epileptic focus appears and the micro-world mutations reveal into the macroworld as matter-energy-information supply (blood flow) to the corresponding parenchyma. At this point, the disease sets in and can be clinically diagnosed, even with conventional instrumental analyses.
Patients with epilepsy, even those who don't suffer from seizures, show a limited brain area (generally a single one), where the microcirculatory remodeling takes place, and which is characterized by clear microcirculatory and parenchymal mutations. Only in cases where flow-motions are highly reduced by microvascular structural and functional mutations, which are typical signs of a remodeling event, can we talk about an epileptic focus, worsened but never caused by known environmental risk factors. The main purpose of the well-structured and refined activity of the tissue microvascular unit supported by the normal viscosity of the local interstice is the physiological regulation of blood flow in vessels under 100 micron, whose role is essential in matter-energy-information supply to the corresponding parenchyma.
It is now clear that any mutation in the refined microcirculatory process has serious repercussions on tissue economy, whose pH reduces, while hydrogen ionic H+ concentration consequently increases, and this is a typical sign of a compromised mitochondrial respiration causing histangic acidosis. QBS diagnostic approach now allows physicians to identify Constitutions and IRRs since birth, that is to say decades before the possible appearance of the corresponding diseases, and this presents the opportunity to perform a rational and detailed pre-primary and primary prevention.
Inherited Real Risk of Epilepsy: QBS Diagnosis
Traditional physical semeiotics does not provide diagnosis of epilepsy in either patients who do not suffer from seizures nor in seizure-affected individuals if the evaluation is made at a distance from seizures. On the contrary, the ReflexDiagnostic-Auscultatory Percussion, which is the eISSN 1303-5150 www.neuroquantology.com basis of QBS, allows physicians to diagnose epilepsy and/or the epileptic focus, both in individuals who just seem to be healthy because they have no symptoms and in those who suffer from epilepsy. In other words, the QBS approach provides the means to easily recognize an epileptic focus long before its clinical appearance. It follows that QBS has a crucial role in the prevention of epileptic seizures. It should be noted, however, that epileptic symptoms and seizures will appear only if the corresponding IRR is particularly serious, i.e. it evolves into an epileptic focus.
To diagnose an IRR of epilepsy, physicians should check in sequence the oculo-gastric aspecific reflex, which is asymmetrical, and the cerebro-gastric aspecific reflex in the cerebral hemisphere previously identified, as well as verify whether a microcirculatory activation type I, associated, is present near the epileptic focus. We should also check QBS preconditioning to verify whether the epileptic disease has already set in (Stagnaro and Neri-Stagnaro, 2004 ).
Patients with epilepsy have the highest Congenital Acidosic Enzyme-Metabolic Histangiopathy (CAEMH) value. Besides CAEMH factor, the following reflexes have a crucial role for the diagnosis of epilepsy: the oculo-gastric aspecific reflex, the microcirculatory activation type I, associated, near the epileptic focus, and the cerebro-gastric aspecific reflex. We explore in details the last one.
Keeping fingers tight together and slightly flexed, physicians should apply nails on frontal region skin, first on the right and then on the left, then crawl up until the corresponding midpoint of the scalp, proceeding from the frontal to the occipital region with very slow movements. When a stimulus (i.e., a mean digital pressure), is exerted directly on skin projection of epileptic focus, a cerebro-gastric aspecific reflex is obtained, which can be further increased with light stimulation, apnoea test, and forced breathing.
We can consider at least 3 significant parameters of this reflex assessment: the latency time (the seconds lasting from the moment of the stimulus to the moment in which the stomach dilates), the intensity (that represents the maximal dilation of the stomach, calculated in centimeters), and the duration. The duration (D) of the cerebro-gastric reflex represents the time in seconds elapsing from the moment of the dilation of the stomach to the moment in which the stomach comes back to the basal position at rest. Compared to "healthy" parameters (the duration of the reflex varies between 3 and 4 seconds in healthy subjects), the duration (D) of the reflex is increased in case of Inherited Real Risk of epilepsy (4 sec. ≤ D < 6 sec.), and this increase is even higher in case of overt pathology (Table 1) with different growing values depending on its severity and clinical evolution (pathology in evolution: 6 < D ≤ 7); (advanced stages of pathology: D > 7). Reflex-Diagnostic-Auscultatory Percussion for cerebral diseases, based on the ancient Auscultatory Percussion technique , is not only useful for epilepsy, but also for the most frequent and serious pathological processes originating from the central nervous system: cerebral cysts, cancer, acute and chronic ischemia, senile cerebral involution, headache, pituitary gland disease, Alzheimer's disease, Parkinson's disease, ALS and even rare diseases such as Friedreich's ataxia.
Inherited Real Risk of Epilepsy and Primary Prevention QBS approach is not only diagnostically relevant, but also useful for an adequate therapeutic monitoring, so as to verify effectiveness of treatments that can be suggested for an appropriate primary and pre-primary therapeutic prevention. There is a class of treatments (i.e., green therapy) that, if adequately combined and integrated, should allow to make a pathological IRR, like the IRR of epilepsy, a residual factor (Stagnaro, 2004b; Marchionni et al., 2013a Marchionni et al., , 2013b Marchionni et al., , 2014 Stagnaro and Caramel, 2011b , 2012a , 2012b , 2013a , 2013b , 2013c , 2013d . To make a risk residual does not mean to remove it completely, but to reduce it to a minimum, i.e. to prevent it from growing and evolving into a disease. This category includes: modified Mediterranean diet combined with daily healthy physical activity, histangic protectors (i.e., conjugated melatonin with the recipe of Di BellaFerrari, substances to improve tissue and mitochondrial oxygenation, coenzyme Q10, vitamins (i.e., vitamin C, orange squeezed juices with the addition of 7 lemon drops), and ascorbates (i.e., potassium ascorbate, sodium ascorbate).
The latest frontier discovered by QBS for pre-primary and primary prevention is a class of treatments known as 'blue therapy' (Stagnaro, 2013) which can heal CAEMH, constitutions, and IRRs completely, if the corresponding diseases have not set in yet. This strengthens and confirms the existing theories on wave genomics, according to Peter Gariaev (1994), and on genetic/genomic reversibility of nuclear and mitochondrial DNA, and especially the principle of Recursive Genome Function introduced by the American crossdisciplinary scientist and technologist Andras Pellionisz (Stagnaro and Caramel, 2011a) . Clinical and experimental evidence of success in healing many pathological IRRs, among which the IRR of epilepsy, comes from the application of millimeter waves in 'Body Resonance Recording' (BRR) mode (Cem-Tech, now Ak-Tom) , from quantum therapy with sodium bicarbonate (Stagnaro, 2015a ) (taking advantage of the extraordinary possibilities provided by quantum medicine combined with frequential information acquired by ad hoc substances, where water acts in harmony with the principle of water information memory), from noni juice (Caramel et al., 2015) and from sulfurous water .
Finally, the QBS experimental evidence highlight the importance of prayers for the health of patients: this practice plays a key role in the following case study reported below (Caramel and Stagnaro, 2011a) .
Results and Discussion
Inherited Real Risk of Epilepsy in Strong Evolution: A Case Study
We report the case of an 11-year-old child with the following pathophysiological basis on May 20th 2013. The patient came to the hospital for tests after episodes characterized by unresponsiveness, with fixed gaze, and slowly falls to the ground, without reporting any serious trauma or head injury, lasting a few seconds, sometimes preceded by complex hallucinatory visions and followed by headache, dizziness, and sometimes vomiting, and slurred speech. The EEG Clinical Report provides the following output: background rhythm characterized by alpha at about 9 cycles per second, irregular, unstable, bilateral, symmetrical and reagent; interspersed on the temporal-parietal regions of the right by activity type PO of medium size with a tendency to spread to the contralateral homologous regions; IPN registers 2 PO bouffées of about 3 cycles per second for a period of 2-3 seconds. The clinical diagnosis is: paroxysmal abnormalities on the right parietal temporal regions with a tendency to spread; bouffées IPN. The suggested therapy is: Levetiracetam 500 in increasing dosage every week.
The child's parents decide to start the prescribed antiepileptic therapy on February 1st 2014, only after an additional episode of seizure. The initial therapy is with Levetiracetam, 125 mg, twice per day.
On February 17th 2014, the senior author (Camponeschi et al., 2013) , founder of Quantum Biophysical Semeiotics, visits the child. The QBS diagnosis is: Intense CAEMH in brain triggerpoints; Inherited Real Risk of Brain Disorder; Inherited Real Risk of Epilepsy in evolution. After this QBS diagnosis the following therapy is applied: Cem-Tech (now Ak-Tom) treatment, i.e. millimeter waves or Extremely High Frequencies (EHF) in the mode of Background Resonance Recording (BRR) on the following trigger-points (Figure 1 ): -1st yellow radiator: CAEMH trigger point (2 cm above the right external ear orifice, that is the skin projection area of CAEMH);
-2nd yellow radiator: on the skin projection of the epileptic focus (in this specific case, upon the superior parietal region; 1 cm above the CAEMH trigger-point).
This is just one application in BRR mode: 60 seconds for capturing body radiations plus 10 minutes of re-radiation.
The patient continues a preventive therapy (resumed in Table 2 ) at home. On May 9th 2014 the child is monitored in the hospital for a 3 days check-up, after 2.5 months from first EHF-BRR treatment, with the following results:
 routine blood tests: within normal range;  3TMRI Brain Skull: no specific diagnostic abnormalities;  cardio-tests ECG: no specific diagnostic abnormalities.  extended video EEG monitoring: vigil and sleep; track with no specific diagnostic abnormalities. Indeed, the prolonged 24 hours video monitoring EEG provides the following results: absence of anomalies; no epileptic forms and asymmetries. The maneuver performed in the induction of symptoms to verify a diagnosis of a functional nature gives no effect. The hospital gives the indication to discontinue the epileptic therapy currently underway at low dosage, so the therapy discharge is to suspend the current antiepileptic therapy with low dose: no therapy at discharge.
The patient spends one more year without any other clinical symptoms, but has relapse episodes in May, 2015.
The senior author visits the child again in September 2015. The QBS tests reveal an impairment of Fe-S clusters (Stagnaro, 2015b (Stagnaro, , 2015c , therefore the customized therapy resumed in Table 1 From QBS viewpoint and in accordance with the above mentioned collected parameters, the inherited risk of epilepsy has reduced and become residual and it will be fully healed as well as the genetic restructuring process will be completed. In fact, the mitochondrial genetic restructuring (Caramel and Stagnaro, 2011b, 2011c ) is still continuing because there is a high physiological microcirculatory activation near the epileptic focus. The current therapeutic monitoring reveals that during the treatment some, but not all, flu viruses, can cause intense tissue acidosis. Although viruses can bring about epileptic seizures, the long term benefits of the ongoing therapy have not reduced.
Conclusion and Directions for Future Research
The most recent studies on the pathogenesis of epilepsy related to maternally inherited mitochondrial DNA genetic mutations confirm the previous clinical and experimental evidence of Quantum Biophysical Semeiotics, which is not only able to diagnose epilepsy at the bedside when the disease has set in, but also to evaluate its Inherited Real Risk already since birth and before its clinical manifestation, thus allowing to perform an efficient customized pre-primary and primary prevention, as evidenced by the study case here reported. Diagnosis and therapeutic monitoring of other similar cases in the near future will allow more accurate and in-depth assessments that integrate the current state of the art with the original preventive diagnostic here introduced.
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